Researchers examined six different subgroups to determine what factors raised or lowered their risk of developing type 2 diabetes.

New research suggests that A1c may play a more prominent role than the duration of diabetes when it comes to respiratory function.

Is current evidence supportive of metformin as an adjunct therapy for pregnant women with diabetes?

Patients with diabetes who have worse glucose control may have a higher risk of infections.

The interaction between systolic blood pressure (SBP) and the effects of empagliflozin in patients with heart failure with reduced ejection fraction (HFrEF).

Insulin is not recommended for COVID-19 patients with T2D due to increased mortality risk,

Dapagliflozin is well studied in type 2 diabetes mellitus and HF and CKD patients with positive results and a good safety profile.

SGLT2 inhibitors are not created equal; patient-specific characteristics need to be considered for best efficacy.

Choosing whole fruits instead of juice could help reduce the risk of type 2 diabetes.

Is weight loss always as beneficial as we think?